Conversely, PRMT7 induction via bindarit treatment enhances cell survival and revascularization, highlighting PRMT7 as a promising therapeutic target for mitigating ischemia-induced cardiomyopathy. The gene discussed is PRMT7; the disease is cardiomyopathy.